<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26426670</article-id>
      <article-id pub-id-type="pmc">4616825</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000001689</article-id>
      <article-id pub-id-type="art-access-id">01689</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>5200</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Chronic Alcoholism</article-title>
        <subtitle>A Case Report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Ming-Hsien</given-names>
          </name>
          <degrees>MD, MPH</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Shih-Hua</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leu</surname>
            <given-names>Jyh-Gang</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>Yu-Wei</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Mubarak.</surname>
            <given-names>Muhammed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital (MHT, JGL, YWF); and Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (SHL).</aff>
      <author-notes>
        <corresp>Correspondence: Yu-Wei Fang, Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (e-mail: <email>M005916@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>02</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <volume>94</volume>
      <issue>39</issue>
      <elocation-id>e1689</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>6</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>1</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>4</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-94-e1689.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Thyrotoxic periodic paralysis (TPP) is characterized by the presence of muscle paralysis, hypokalemia, and hyperthyroidism. We report the case of a young man with paralysis of the lower extremities, severe hypokalemia, and concurrent hyperthyroidism. TPP was suspected; therefore, treatment consisting of judicious potassium (K<sup>+</sup>) repletion and &#x3B2;-blocker administration was initiated. However, urinary K<sup>+</sup> excretion rate, as well as refractoriness to treatment, was inconsistent with TPP. Chronic alcoholism was considered as an alternative cause of hypokalemia, and serum K<sup>+</sup> was restored through vigorous K<sup>+</sup> repletion and the addition of K<sup>+</sup>-sparing diuretics.</p>
        <p>The presence of thyrotoxicosis and hypokalemia does not always indicate a diagnosis of TPP. Exclusion of TPP can be accomplished by immediate evaluation of urinary K<sup>+</sup> excretion, acid-base status, and the amount of potassium chloride required to correct hypokalemia at presentation.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hypokalemic paralysis, commonly observed in patients presenting to the emergency department, may be caused by neurologic, metabolic, or renal disorders. There is a high incidence of thyrotoxic periodic paralysis (TPP) among Asians, although the incidence has been recently increasing in Western countries because of global immigration.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Excessive thyroid hormone levels can provoke abrupt intracellular shift of potassium (K<sup>+</sup>), thus causing paralysis. In cases of patients presenting with hypokalemic paralysis and hyperthyroidism, TPP is generally considered as the initial diagnosis. However, this diagnosis may be erroneous in rare cases owing to conditions that cause renal or nonrenal K<sup>+</sup> loss. Incorrect diagnosis may cause the implementation of an inappropriate strategy of K<sup>+</sup> repletion and recurrent hypokalemia. The use of simple, fast, and inexpensive tests of blood and urine electrolytes, and acid-base status may aid in differentiating such disorders.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> This could be illustrated by the following young male presenting with hypokalemic paralysis, who was initially misdiagnosed as TPP, but established to have the etiology of chronic alcoholism.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 33-year-old Chinese man with a family history of hyperthyroidism presented to the emergency department of our institution with a 5-day history of progressive muscular weakness and paralysis of the lower extremities. Symptoms such as nausea, vomiting, diarrhea, or lower-extremity numbness were absent. There was no history of recent strenuous exercise or diuretic use. The patient was a chronic alcoholic for more than 10 years and reported excessive drinking the week before symptom onset. On physical examination, blood pressure was 116/64&#x200A;mm Hg, heart rate was 82&#x200A;beats/min, respiratory rate was 22&#x200A;breaths/min, body temperature was 36.8 &#xB0;C, and the patient had symmetrical flaccid paralysis of the lower extremities with areflexia. The remainder of the physical examination was unremarkable.</p>
      <p>The biochemical studies are shown in Table <xref ref-type="table" rid="T1">1</xref>. Severe hypokalemia (1.6&#x200A;mmol/L) with metabolic alkalosis (bicarbonate 36&#x200A;mmol/L) was the prominent finding. Serial urine electrolytes examined during admission indicated an inconsistent K<sup>+</sup> excretion rate (transtubular potassium gradient [TTKG] 7.06 and urinary K<sup>+</sup>-creatinine ratio [K<sup>+</sup>/Cr] 3.97 on day 1, but TTKG 0.84 and urinary K<sup>+</sup>/Cr 1.84 in day 2). Hormone profile, including thyroid-stimulating hormone (&lt;0.005&#x200A;mIU/L; reference range 0.27&#x2013;4.2), free thyroxine (fT<sub>4</sub>) (24&#x200A;pmol/L; reference range 11.6&#x2013;21.2), and cortisol (507.6&#x200A;nmol/L; reference range 171.0&#x2013;535.2), indicated hyperthyroidism. The initial diagnosis was TPP, and nonselective &#x3B2;-blocker therapy (propranolol 60&#x200A;mg/day) with cautious K<sup>+</sup> supplementation was administered. However, serum K<sup>+</sup> level remained unchanged for several hours (Figure <xref ref-type="fig" rid="F1">1</xref>). Because the patient also had metabolic alkalosis and high urinary K<sup>+</sup> excretion, which suggested a severe K<sup>+</sup> deficit associated with chronic alcoholism rather than acute hypokalemia with relatively normal acid-base status as seen in TPP, he received a larger dose of K<sup>+</sup> supplement along with the addition of spironolactone. A total of 372 mmol of potassium chloride (KCl) was needed to achieve normal serum K<sup>+</sup> concentration and restore his muscle strength (Figure <xref ref-type="fig" rid="F1">1</xref>). Three days later, the patient had normal serum K<sup>+</sup> level and did not develop hyperkalemia. He was discharged with antithyroid treatment and was persuaded to cease alcohol consumption. At the 1-month follow-up, his serum K<sup>+</sup> concentration was 3.6&#x200A;mmol/L without KCl supplementation.</p>
      <table-wrap id="T1" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Serum and Urinary Laboratory Data During Admission</p>
        </caption>
        <graphic xlink:href="medi-94-e1689-g001"/>
      </table-wrap>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Relationship between serum potassium level and dose of potassium supplementation. The patient's serum level of potassium returned to normal in 44&#x200A;h after supplementation with 372 mmol of potassium chloride.</p>
        </caption>
        <graphic xlink:href="medi-94-e1689-g002"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Hypokalemia is a common but potentially life-threatening electrolyte abnormality because it may induce cardiac arrhythmia and respiratory failure. The most essential role of K<sup>+</sup> is to keep the transmembrane's electrochemical gradient. Short-term homeostasis of the serum concentration of K<sup>+</sup> is determined on a minute-to-minute basis by the K<sup>+</sup> shifting between intracellular and extracellular fluid compartments. Nevertheless, long-term homeostasis of serum K<sup>+</sup> level depends on a day-to-day basis by the regulation of renal K<sup>+</sup> excretion. Therefore, the etiologies of hypokalemia usually are a shift of K<sup>+</sup> into cells and/or excessive renal or extrarenal K<sup>+</sup> loss.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup> Hypokalemic periodic paralysis contains any hypokalemic disease caused by acute shift of K<sup>+</sup> into cells. Two most common subgroups are identified. One is TPP, which is mainly observed in Asians, and the other is familial periodic paralysisis, which is induced by calcium or sodium channelopathies of skeletal muscle and predominantly seen in Caucasians.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup> TPP can manifest with hyperthyroidism of any etiology. Hyperthyroidism can induce a hyperadrenergic state.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Stimulation of &#x3B2;2-adrenergic receptor in muscle cells may directly promote cellular K<sup>+</sup> uptake by increasing intracellular cyclic adenosine monophosphate, which thus can lead to activation of the Na<sup>+</sup>-K<sup>+</sup>-ATPase pump.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> Moreover, thyroid hormone has a similar chemical structure to that of catecholamines, which can directly activate the Na<sup>+</sup>-K<sup>+</sup>-ATPase pump and concurrently increase the number and sensitivity of &#x3B2;-receptors.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p>
      <p>Chronic alcoholism is usually associated with electrolyte abnormalities and metabolic alkalosis. Although disturbances in magnesium and phosphorus homeostasis can occur in these patients, hypokalemia is found more frequently.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> The causes of hypokalemia in alcoholism include poor intake, gastrointestinal loss (diarrhea or vomiting), hypomagnesemia, and renal tubular dysfunction. The exact mechanism underlying renal K<sup>+</sup> loss is unclear, but hypomagnesaemia, which may open K<sup>+</sup> channels in the luminal membrane of the distal tubules and increase K<sup>+</sup> excretion, may be involved.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Accordingly, in the hypokalemic state associated with chronic alcoholism, the urinary K<sup>+</sup> excretion rate is inconsistent, and may be high because of renal tubule dysfunction or low because of gastrointestinal K<sup>+</sup> loss or poor K<sup>+</sup> intake. In the present case, the serum magnesium level was normal and serum K<sup>+</sup> was elevated merely by K<sup>+</sup> supplementation without additional magnesium administration, suggesting that magnesium played a minor role in this condition.</p>
      <p>The causes and differential diagnosis of hypokalemia are shown in Figure <xref ref-type="fig" rid="F2">2</xref>. Assessment of urinary K<sup>+</sup> excretion rate and blood acid-base state is paramount to help determine the cause of hypokalemic paralysis. TTKG (reference range 3) or spot urinary K<sup>+</sup>-creatinine ratio (reference range 2.0&#x200A;mmol/mmol) can be used as an index of urinary K<sup>+</sup> excretion rate. If a low urinary K<sup>+</sup> excretion rate is noted, extrarenal loss or hypokalemic periodic paralysis should be considered. In HPP, including TPP, the acid-base state is relatively normal, whereas in the presence of extrarenal causes such as gastrointestinal disorder, metabolic alkalosis or acidosis usually occurs.<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup> If a high urinary K<sup>+</sup> secretion rate is present, abnormal values of blood acid-base state and blood pressure provide useful information. Coexisting metabolic acidosis suggests the presence of renal tubular acidosis (RTA), toluene use, severe diarrhea, or ureteral diversion. The presence of hypertension with metabolic alkalosis indicates excess of mineralocorticoids. The presence of normal blood pressure and metabolic alkalosis indicates genetic renal tubulopathy (Gitelman syndrome and Bartter syndrome), severe diarrhea, vomiting, diuretic use, or alcoholism-induced renal tubular dysfunction.<sup><xref rid="R2" ref-type="bibr">2</xref>&#x2013;<xref rid="R4" ref-type="bibr">4</xref></sup></p>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Approach to hypokalemic patients.<sup><xref rid="R2" ref-type="bibr">2</xref>&#x2013;<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup> Abbreviation: Aldo, aldosterone; ACTH, adrenocorticotropic hormone; AME, apparent mineralcocorticoid excess syndrome.</p>
        </caption>
        <graphic xlink:href="medi-94-e1689-g003"/>
      </fig>
      <p>In the present case, the first spot urine analysis performed at the emergency department showed a high urinary K<sup>+</sup> excretion rate. Vomiting, diarrhea, and diuretic use were absent. A serial urinary electrolyte excretion did not support the diagnosis of genetic renal tubular disorders such as Bartter and Gitelman syndrome, with persistent high urinary NaCl excretion and divalent abnormality in blood and urine. TPP was highly suspected solely because of the presence of hyperthyroidism and hypokalemia. However, &#x3B2;-blocker administration to treat the acute onset of TPP coupled with K<sup>+</sup> supplementation for several hours failed to elevate serum K<sup>+</sup> concentration, inconsistent with the typical course of TPP. The recognition of concurrent chronic alcoholism and the presence of metabolic alkalosis, high renal K<sup>+</sup> secretion rate, and low urine calcium/phosphate ratio (usually more than 1.7 in TPP)<sup><xref rid="R2" ref-type="bibr">2</xref></sup> in the first spot urine assessment prompted us to associate the severe K<sup>+</sup> deficit with chronic alcoholism as the primary cause. TPP can be triggered by alcohol consumption.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> However, in the present case, increase in the dose of K<sup>+</sup> supplement did not result in development of rebound hyperkalemia on recovery, as is usually seen in most cases of TPP<sup><xref rid="R16" ref-type="bibr">16</xref></sup>; this was an additional indicator that the diagnosis of TPP was incorrect.</p>
      <p>In conclusion, a provisional diagnosis of TPP was premature when facing a patient presenting with hypokalemia and hyperthyroidism. A detailed history, careful physical examination, urinary K<sup>+</sup> excretion rate, and blood acid-base state may help determine the cause of hypokalemia.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGMENT</title>
      <p>We thank our patient for contributing clinical data to this report.</p>
    </ack>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: TPP = thyrotoxic periodic paralysis, K<sup>+</sup> = potassium, TTKG = transtubular potassium gradient, K<sup>+</sup>/Cr = potassium-creatinine ratio, KCl = potassium chloride.</p>
      </fn>
      <fn fn-type="other">
        <p>Ethical statement: Ethical approval was not necessary for this study as our study was focused on the retrospective observation of a patient's hospital course, which did in no way to affect his treatment. Informed Consent was obtained from the patient regarding the reporting and publication of this case report.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><source>Lin SH. Thyrotoxic periodic paralysis. Mayo Clinic proceedings. Mayo Clinic</source>
<year>2005</year>;<volume>80</volume>:<fpage>99</fpage>&#x2013;<lpage>105</lpage>.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SH</given-names></name><name><surname>Lin</surname><given-names>YF</given-names></name><name><surname>Chen</surname><given-names>DT</given-names></name><etal/></person-group>
<article-title>Laboratory tests to determine the cause of hypokalemia and paralysis</article-title>. <source><italic>Arch Internal Med</italic></source>
<year>2004</year>; <volume>164</volume>:<fpage>1561</fpage>&#x2013;<lpage>1566</lpage>.<pub-id pub-id-type="pmid">15277290</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SH</given-names></name><name><surname>Chiu</surname><given-names>JS</given-names></name><name><surname>Hsu</surname><given-names>CW</given-names></name><etal/></person-group>
<article-title>A simple and rapid approach to hypokalemic paralysis</article-title>. <source><italic>Am J Emerg Med</italic></source>
<year>2003</year>; <volume>21</volume>:<fpage>487</fpage>&#x2013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">14574658</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SH</given-names></name><name><surname>Halperin</surname><given-names>ML</given-names></name></person-group>
<article-title>Hypokalemia: a practical approach to diagnosis and its genetic basis</article-title>. <source><italic>Curr Med Chem</italic></source>
<year>2007</year>; <volume>14</volume>:<fpage>1551</fpage>&#x2013;<lpage>1565</lpage>.<pub-id pub-id-type="pmid">17584063</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halperin</surname><given-names>ML</given-names></name><name><surname>Kamel</surname><given-names>KS</given-names></name></person-group>
<article-title>Potassium</article-title>. <source><italic>Lancet</italic></source>
<year>1998</year>; <volume>352</volume>:<fpage>135</fpage>&#x2013;<lpage>140</lpage>.<pub-id pub-id-type="pmid">9672294</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>GT</given-names></name><name><surname>Chow</surname><given-names>CC</given-names></name><name><surname>Yeung</surname><given-names>VT</given-names></name><etal/></person-group>
<article-title>Thyrotoxic periodic paralysis in a Chinese population</article-title>. <source><italic>QJM</italic></source>
<year>1996</year>; <volume>89</volume>:<fpage>463</fpage>&#x2013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">8758050</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>GS</given-names></name><name><surname>Klein</surname><given-names>I</given-names></name></person-group>
<article-title>Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism</article-title>. <source><italic>Am J Med</italic></source>
<year>1990</year>; <volume>88</volume>:<fpage>642</fpage>&#x2013;<lpage>646</lpage>.<pub-id pub-id-type="pmid">2189309</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MJ</given-names></name><name><surname>Brown</surname><given-names>DC</given-names></name><name><surname>Murphy</surname><given-names>MB</given-names></name></person-group>
<article-title>Hypokalemia from beta2-receptor stimulation by circulating epinephrine</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1983</year>; <volume>309</volume>:<fpage>1414</fpage>&#x2013;<lpage>1419</lpage>.<pub-id pub-id-type="pmid">6314140</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>AM</given-names></name><name><surname>Clutter</surname><given-names>WE</given-names></name><name><surname>Shah</surname><given-names>SD</given-names></name><etal/></person-group>
<article-title>Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man</article-title>. <source><italic>J Clin Investig</italic></source>
<year>1981</year>; <volume>67</volume>:<fpage>1785</fpage>&#x2013;<lpage>1791</lpage>.<pub-id pub-id-type="pmid">6263953</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elisaf</surname><given-names>M</given-names></name><name><surname>Merkouropoulos</surname><given-names>M</given-names></name><name><surname>Tsianos</surname><given-names>EV</given-names></name><etal/></person-group>
<article-title>Acid-base and electrolyte abnormalities in alcoholic patients</article-title>. <source><italic>Mineral Electrolyte Metab</italic></source>
<year>1994</year>; <volume>20</volume>:<fpage>274</fpage>&#x2013;<lpage>281</lpage>.</mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Marchi</surname><given-names>S</given-names></name><name><surname>Cecchin</surname><given-names>E</given-names></name><name><surname>Basile</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Renal tubular dysfunction in chronic alcohol abuse: effects of abstinence</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1993</year>; <volume>329</volume>:<fpage>1927</fpage>&#x2013;<lpage>1934</lpage>.<pub-id pub-id-type="pmid">8247056</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elisaf</surname><given-names>M</given-names></name><name><surname>Liberopoulos</surname><given-names>E</given-names></name><name><surname>Bairaktari</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Hypokalaemia in alcoholic patients</article-title>. <source><italic>Drug Alcohol Rev</italic></source>
<year>2002</year>; <volume>21</volume>:<fpage>73</fpage>&#x2013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">12189007</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>WF</given-names></name><name><surname>Hsu</surname><given-names>YJ</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>Hypokalemic paralysis in a young obese female</article-title>. <source><italic>Clin Chim Acta</italic></source>
<year>2012</year>; <volume>413</volume>:<fpage>1295</fpage>&#x2013;<lpage>1297</lpage>.<pub-id pub-id-type="pmid">22521493</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>CC</given-names></name><name><surname>Cheng</surname><given-names>CJ</given-names></name><name><surname>Chiang</surname><given-names>WF</given-names></name><etal/></person-group>
<article-title>Etiologic and therapeutic analysis in patients with hypokalemic nonperiodic paralysis</article-title>. <source><italic>Am J Med</italic></source>
<year>2015</year>; <volume>128</volume>:<fpage>289-296 e281</fpage>.<pub-id pub-id-type="pmid">25447623</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>P</given-names></name></person-group>
<article-title>Hypokalemic thyrotoxic periodic paralysis: a case series</article-title>. <source><italic>Cjem</italic></source>
<year>2003</year>; <volume>5</volume>:<fpage>353</fpage>&#x2013;<lpage>355</lpage>.<pub-id pub-id-type="pmid">17466146</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>KC</given-names></name><name><surname>Hsu</surname><given-names>YJ</given-names></name><name><surname>Chiu</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis</article-title>. <source><italic>Am J Emerg Med</italic></source>
<year>2004</year>; <volume>22</volume>:<fpage>544</fpage>&#x2013;<lpage>547</lpage>.<pub-id pub-id-type="pmid">15666258</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
